Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

VANTAGE STUDY Vercise™ Implantable Stimulator for Treating Parkinson's Disease

NCT01221948 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT01221948
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01221948 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
VANTAGE STUDY Vercise™ Implantable Stimulator for Treating Parkinson's Disease
Lead sponsor
Boston Scientific Corporation
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2010
Completion date
June 1, 2018
Enrollment
53 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic parkinson's disease